Filing Flows › Lucid Diagnostics (LUCD) › Q1 2026
Lucid Diagnostics (LUCD) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 13, 2026
Lucid Diagnostics (LUCD) reported revenue of $1.3M for the first quarter 2026 (Q1 2026), +52% from a year earlier and -16% from the quarter before. Operating margin was -964.5%.
Lucid Diagnostics, Q1 2026: revenue $1.3M (+52% year over year), operating margin -964.5%, net loss $13.9M, operating cash flow −$12.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | -16% | +52% |
| Operating profit | −$12.1M | — | — |
| Net earnings | −$13.9M | — | — |
| Operating cash flow | −$12.1M | — | — |
What changed
Revenue was $1.3M in Q1 2026, up 52% year over year and down 16% from the previous quarter.
Operating costs exceeded revenue by $12.1M, an operating margin of -964.5%. Total costs grew 0% against revenue growth of 52%. The fastest-growing cost line was Sales & marketing (+23%). The quarter ended with a net loss of $13.9M, narrower than the previous quarter's $16.3M loss.
Operating cash flow was −$12.1M. Non-cash charges added back $222K of depreciation and amortization and $1.4M of share-based compensation. Capital expenditures of $215K exceeded it, leaving free cash flow of −$12.3M.
Questions
What was Lucid Diagnostics' revenue in the first quarter 2026?
Lucid Diagnostics (LUCD) reported revenue of $1.3M for the first quarter 2026 (Q1 2026), +52% from a year earlier and -16% from the quarter before.
Was Lucid Diagnostics profitable in the first quarter 2026?
Operating loss was $12.1M (-964.5% of revenue) and net loss $13.9M.
Source: Lucid Diagnostics 10-Q on SEC EDGAR.